Predictive factors of tumor response and prognostic factors of survival during lung cancer chemotherapy

被引:44
|
作者
Ray, P [1 ]
Quantin, X [1 ]
Grenier, J [1 ]
Pujol, JL [1 ]
机构
[1] CHU Montpellier, Hop Arnaud de Villeneuve, Serv Malad Resp, F-34295 Montpellier, France
来源
CANCER DETECTION AND PREVENTION | 1998年 / 22卷 / 04期
关键词
chemotherapy; CYFRA; 21-1; cytokeratins; lung cancer; neuron-specific enolase; survival; tissue polypeptide-specific antigen; tumor markers; tumor response;
D O I
10.1046/j.1525-1500.1998.CDOA43.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was (i) to determine predictive factors of a complete response to chemotherapy in small cell lung cancer (SCLC) and predictive factors of an objective response in non-small cell lung cancer (NSCLC) and (ii) to determine whether prognostic factors are different with regard to treatment response and survival. Ninety-nine patients with SCLC and two hundred and two patients with NSCLC received chemotherapy. The following variables were recorded prior to treatment: tumor, node, metastasis status, performance status, body weight loss, blood leukocyte count, serum sodium, serum albumin, lactate dehydrogenase (LDH), alkaline phosphatase, serum NSE, serum TPS, and serum CYFRA 21-1. Tumor response was analyzed at the 10th week. Analysis of survival were done using the landmark method. Hazard ratios of the significant prognostic variables of survival were calculated using the Cox's model. Odds ratios of the significant predicting factors of response were calculated by stepwise logistic regression. In SCLC, the significant determinants of poor survival were: lack of complete response (HR: 2.04), weight loss (HR: 1.76), high serum LDH level (HR: 1.64), and high serum TPS level (HR: 2.47). A high serum TPS level was the only factor among those studied able to predict lack of achievement of complete response (OR: 0.39). In NSCLC, significant determinants of poor survival were: no objective response (HR: 2.28), poor performance status (HR: 2.52), presence of metastases (HR: 1.51), and high serum CYFRA 21-1 level (HR: 1.84). On the other hand, a high serum TPS level (OR: 0.50), the presence of metastases (OR: 0.45), and a leukocyte blood count over 10,000/mu l (OR: 0.43) were independent determinants for a patient not to achieve an objective response. We concluded that the predictive factors of complete response in SCLC remain to be defined. On the other hand, in NSCLC three variables contribute to the prediction of an objective response. Finally, determinants of survival differ from predictive factors of response.
引用
收藏
页码:293 / 304
页数:12
相关论文
共 50 条
  • [41] Prognostic Factors Affecting Survival in Advanced Non-Small Cell Lung Cancer Patients
    Songur, Necla
    Kuru, Bekir
    Ok, Ugur
    TURKISH THORACIC JOURNAL, 2005, 6 (02) : 91 - 97
  • [42] Prognostic Factors of Survival After Radiotherapy for Lung Cancer-The Impact of Smoking Pack Years
    Werner, Elisa M.
    Glatzel, Esther
    Bohnet, Sabine
    Schild, Steven E.
    Rades, Dirk
    IN VIVO, 2022, 36 (03): : 1297 - 1301
  • [43] Non-small cell lung cancer.: Survival after radiotherapy and prognostic factors
    Olasolo, JJ
    Redondo, EA
    Jiménez, AL
    Ramos, AR
    ARCHIVOS DE BRONCONEUMOLOGIA, 2003, 39 (02): : 81 - 86
  • [44] Examination of the predictive factors of the response to whole brain radiotherapy for brain metastases from lung cancer using MRI
    Aoki, Shuri
    Kanda, Tomonori
    Matsutani, Noriyuki
    Seki, Nobuhiko
    Kawamura, Masafumi
    Furui, Shigeru
    Yamashita, Hideomi
    ONCOLOGY LETTERS, 2017, 14 (01) : 1073 - 1079
  • [45] Epidemiological profile and prognostic factors in patients with lung cancer
    Trufelli, Damila Cristina
    Moraes, Thayles Vinicius
    Porto Rocha Lima, Aline Angelica
    Del Giglio, Auro
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (05): : 428 - 433
  • [46] Multivariate analysis of prognostic factors in patients with lung cancer
    Liu, Changjiang
    Ma, Minting
    Zhou, Xuetao
    Zhang, Zefeng
    Guo, Yang
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [47] Immunologic parameters as significant prognostic factors in lung cancer
    Nakamura, H
    Saji, H
    Ogata, A
    Hosaka, M
    Hagiwara, M
    Kawasaki, N
    Konaka, C
    Kato, H
    LUNG CANCER, 2002, 37 (02) : 161 - 169
  • [48] Characterization of the prognostic values and response to immunotherapy/chemotherapy of Kruppel-like factors in prostate cancer
    Meng, Jialin
    Lu, Xiaofan
    Zhou, Yujie
    Zhang, Meng
    Gao, Lei
    Gao, Shenglin
    Yan, Fangrong
    Liang, Chaozhao
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (10) : 5797 - 5810
  • [49] Toward a personalized treatment of colorectal cancer: prognostic and predictive factors
    Lievre, A.
    ONCOLOGIE, 2010, 12 (10) : 584 - 592
  • [50] Emerging Prognostic and Predictive Factors in Pancreatic Cancer
    Karamitopoulou, Eva
    MODERN PATHOLOGY, 2023, 36 (11)